A Pharmacokinetic Participation Questionnaire Study
- To use a simple 2-page survey to gather preliminary information on why patients or
parents/guardians (if patient is a minor) do or do not agree to participate in the
optional pharmacokinetic portion of a phase I treatment study while consenting to
participate in the phase I treatment study.
OUTLINE: This is a multicenter study.
Patients or parents/guardians (if patient is a minor) complete a short questionnaire on the
reasons for agreeing/declining to participation in the optional pharmacokinetic sampling
component of the phase I clinical trial.
Patient demographics and other relevant information are collected.
Correlation between study questionnaire answers and patient demographics
Elizabeth Fox, MD
National Cancer Institute (NCI)
United States: Federal Government